- Home
- MRK
as 10-24-2025 3:49pm EST
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Upcoming Earnings Alert:
Get ready for potential market movements as Merck & Company Inc. (new) MRK prepares to release earnings report on 30 Oct 2025.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | RAHWAY |
| Market Cap: | 218.8B | IPO Year: | N/A |
| Target Price: | $105.14 | AVG Volume (30 days): | 12.0M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 6.49 | EPS Growth: | 20.41 |
| 52 Week Low/High: | $73.31 - $106.62 | Next Earning Date: | 10-30-2025 |
| Revenue: | $63,616,000,000 | Revenue Growth: | 1.82% |
| Revenue Growth (this year): | 1.76% | Revenue Growth (next year): | 5.11% |
Latest Merck & Company Inc. (new) News
MRK Breaking Stock News: Dive into MRK Ticker-Specific Updates for Smart Investing
GlobeNewswire
20 hours ago
United States Lipid Nanoparticle Market Forecast and Competitive Analysis Report 2025-2033 Featuring Merck, Evonik, Genevant Sciences, CordenPharma, Arcturus, Ascendia, Acuitas, Croda
PR Newswire
2 days ago
eschbach's Shiftconnector® Helps Power Merck's Visual Factory to Drive Greater Transparency, Agility, and Supply Chain Resilience
Zacks
2 days ago
Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
GuruFocus.com
2 days ago
Trump's Next Shock Move: U.S. Weighs Software Ban That Could Hit China's Tech Core
Business Wire
2 days ago
Net Asset Value(s)
MT Newswires
2 days ago
NioCorp, Lockheed Martin Collaborate on Scandium-Based Defense Technology
MT Newswires
2 days ago
BofA Securities Adjusts Price Target on NVR to $9,200 From $9,000, Maintains Buy Rating
MT Newswires
2 days ago
BofA Securities Adjusts Bumble Price Target to $5 From $5.50, Maintains Underperform Rating
Compare MRK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRK Merck & Company Inc. (new) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.